Activated Akt phosphorylates tuberous sclerosis complex 2 (TSC2) and relieves its inhibitory effect on mTOR, leading to mTOR activation and increased synthesis of multiple oncogenic proteins to promote cancer progression [93]. This evidence concerns the gene MTOR and cancer.